Variant report

Variant	nsv583591
Chromosome Location	chr2:168037489-168132892
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:168068591-168068899	HepG2	liver:	n/a	n/a
2	ATF2	chr2:168131268-168131939	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr2:168128467-168128750	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr2:168111908-168111943	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr2:168072149-168072519	H1-hESC	embryonic stem cell:	n/a	n/a
6	CEBPB	chr2:168053490-168053948	ECC-1	luminal epithelium:	n/a	chr2:168053754-168053767 chr2:168053869-168053882 chr2:168053869-168053880
7	CEBPB	chr2:168052066-168052382	HepG2	liver:	n/a	chr2:168052217-168052228 chr2:168052303-168052320
8	CEBPB	chr2:168066976-168067279	HepG2	liver:	n/a	chr2:168067118-168067131 chr2:168067119-168067130
9	CEBPB	chr2:168084376-168084576	HepG2	liver:	n/a	chr2:168084429-168084440 chr2:168084391-168084404
10	CEBPB	chr2:168066251-168066678	ECC-1	luminal epithelium:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
11	CEBPB	chr2:168052089-168052385	IMR90	lung:	n/a	chr2:168052217-168052228 chr2:168052303-168052320
12	CEBPB	chr2:168105742-168106088	HepG2	liver:	n/a	chr2:168105897-168105908
13	CEBPB	chr2:168088643-168088871	IMR90	lung:	n/a	chr2:168088719-168088728 chr2:168088716-168088733 chr2:168088717-168088728 chr2:168088718-168088729
14	CEBPB	chr2:168105757-168106028	H1-hESC	embryonic stem cell:	n/a	chr2:168105897-168105908
15	CEBPB	chr2:168130867-168131125	H1-hESC	embryonic stem cell:	n/a	chr2:168130925-168130938 chr2:168130925-168130938
16	CEBPB	chr2:168066351-168066636	Hela-S3	cervix:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
17	CEBPB	chr2:168066274-168066660	IMR90	lung:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
18	CEBPB	chr2:168066295-168066625	K562	blood:	n/a	chr2:168066466-168066477
19	CEBPB	chr2:168088629-168088894	HepG2	liver:	n/a	chr2:168088719-168088728 chr2:168088716-168088733 chr2:168088717-168088728 chr2:168088718-168088729
20	CEBPB	chr2:168066329-168066648	MCF-7	breast:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
21	CEBPB	chr2:168066996-168067238	IMR90	lung:	n/a	chr2:168067118-168067131 chr2:168067119-168067130
22	CEBPB	chr2:168105746-168106060	IMR90	lung:	n/a	chr2:168105897-168105908
23	CEBPB	chr2:168066272-168066572	ECC-1	luminal epithelium:	n/a	chr2:168066466-168066477
24	CEBPB	chr2:168054671-168054853	H1-hESC	embryonic stem cell:	n/a	chr2:168054819-168054830
25	CEBPB	chr2:168066297-168066645	H1-hESC	embryonic stem cell:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
26	CEBPB	chr2:168053553-168053939	ECC-1	luminal epithelium:	n/a	chr2:168053754-168053767 chr2:168053869-168053882 chr2:168053869-168053880
27	CEBPB	chr2:168066288-168066658	HepG2	liver:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
28	CEBPB	chr2:168053567-168053900	IMR90	lung:	n/a	chr2:168053754-168053767 chr2:168053869-168053882 chr2:168053869-168053880
29	CEBPB	chr2:168084355-168084536	A549	lung:	n/a	chr2:168084429-168084440 chr2:168084391-168084404
30	CEBPB	chr2:168105756-168106072	A549	lung:	n/a	chr2:168105897-168105908
31	CEBPB	chr2:168054672-168054862	HepG2	liver:	n/a	chr2:168054819-168054830
32	CEBPB	chr2:168066283-168066646	A549	lung:	n/a	chr2:168066612-168066629 chr2:168066466-168066477
33	CEBPB	chr2:168120950-168121196	MCF-7	breast:	n/a	n/a
34	CEBPB	chr2:168037710-168038055	IMR90	lung:	n/a	n/a
35	CHD1	chr2:168068438-168069007	IMR90	lung:	n/a	n/a
36	CTCF	chr2:168068600-168068886	HepG2	liver:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
37	CTCF	chr2:168068680-168068830	AG09309	skin:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
38	CTCF	chr2:168068640-168068790	GM12873	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
39	CTCF	chr2:168068680-168068830	HEK293	kidney:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
40	CTCF	chr2:168068660-168068810	GM12868	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
41	CTCF	chr2:168068660-168068810	GM12867	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
42	CTCF	chr2:168125211-168125369	HepG2	liver:	n/a	n/a
43	CTCF	chr2:168121000-168121150	HCFaa	heart:	n/a	n/a
44	CTCF	chr2:168068580-168068730	NHLF	lung:	n/a	n/a
45	CTCF	chr2:168068677-168068788	MCF-7	breast:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
46	CTCF	chr2:168068680-168068830	GM06990	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
47	CTCF	chr2:168094112-168094246	HepG2	liver:	n/a	n/a
48	CTCF	chr2:168068700-168068850	BJ	skin:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
49	CTCF	chr2:168068680-168068830	GM12874	blood:	n/a	chr2:168068752-168068770 chr2:168068754-168068767 chr2:168068753-168068769 chr2:168068747-168068768
50	CTCF	chr2:168120961-168121210	Pancreas_OC	pancreas:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:168130989-168131039	U87	brain:	n/a
2	chr2:168130989-168131039	U87	brain:	n/a
3	chr2:168121101-168121151	NHBE	bronchial:	n/a
4	chr2:168115266-168115316	HEEpiC	esophagus:	n/a
5	chr2:168121101-168121151	HRCEpiC	kidney:	n/a
6	chr2:168103543-168103593	NT2-D1	testis:	n/a
7	chr2:168130989-168131039	HRE	kidney:	n/a
8	chr2:168130989-168131039	BJ	skin:	n/a
9	chr2:168042982-168043032	HCPEpiC	choroid plexus:	n/a
10	chr2:168103475-168103525	ProgFib	skin:	n/a
11	chr2:168104087-168104137	LNCaP	prostate:	n/a
12	chr2:168104087-168104137	GM12892	blood:	n/a
13	chr2:168115266-168115316	NH-A	brain:	n/a
14	chr2:168103475-168103525	HCF	heart:	n/a
15	chr2:168104087-168104137	HRE	kidney:	n/a
16	chr2:168103543-168103593	GM06990	blood:	n/a
17	chr2:168130989-168131039	PrEC	prostate:	n/a
18	chr2:168121101-168121151	SK-N-SH_RA	brain:	n/a
19	chr2:168115266-168115316	AoSMC	blood vessel:	n/a
20	chr2:168103475-168103525	HAEpiC	amniotic membrane:	n/a
21	chr2:168115266-168115316	HRCEpiC	kidney:	n/a
22	chr2:168103543-168103593	MCF10A-Er-Src	breast:	n/a
23	chr2:168103475-168103525	SK-N-SH_RA	brain:	n/a
24	chr2:168103543-168103593	HCT-116	colon:	n/a
25	chr2:168042982-168043032	HCF	heart:	n/a
26	chr2:168103475-168103525	MCF10A-Er-Src	breast:	n/a
27	chr2:168103475-168103525	HL-60	blood:	n/a
28	chr2:168103475-168103525	K562	blood:	n/a
29	chr2:168103543-168103593	NHBE	bronchial:	n/a
30	chr2:168104087-168104137	HRCEpiC	kidney:	n/a
31	chr2:168130989-168131039	Caco-2	colon:	n/a
32	chr2:168104087-168104137	HEEpiC	esophagus:	n/a
33	chr2:168103475-168103525	HRCEpiC	kidney:	n/a
34	chr2:168130989-168131039	NH-A	brain:	n/a
35	chr2:168121101-168121151	ovcar-3	ovarian:	n/a
36	chr2:168042982-168043032	HMEC	breast:	n/a
37	chr2:168042982-168043032	SKMC	muscle:	n/a
38	chr2:168103475-168103525	GM06990	blood:	n/a
39	chr2:168103543-168103593	H1-hESC	embryonic stem cell:	embryo
40	chr2:168121101-168121151	AG04449	skin:	fetal
41	chr2:168103543-168103593	NHDF-neo	bronchial:	n/a
42	chr2:168130989-168131039	PFSK-1	brain:	n/a
43	chr2:168115266-168115316	AG04449	skin:	fetal
44	chr2:168103543-168103593	MCF-7	breast:	n/a
45	chr2:168103543-168103593	PrEC	prostate:	n/a
46	chr2:168042982-168043032	HAEpiC	amniotic membrane:	n/a
47	chr2:168103543-168103593	SAEC	small airway:	n/a
48	chr2:168121101-168121151	NB4	blood:	n/a
49	chr2:168104087-168104137	Caco-2	colon:	n/a
50	chr2:168104087-168104137	H1-hESC	embryonic stem cell:	embryo

No.	Distal block	Cell Line	Cell type
1	chr2:168082475..168084083-chr2:168084397..168086061,2	MCF-7	breast:
2	chr2:168089396..168091403-chr2:168092947..168095096,2	K562	blood:
3	chr2:167395585..167396612-chr2:168068492..168069153,3	MCF-7	breast:
4	chr2:168089396..168091403-chr2:168092947..168095096,2	K562	blood:
5	chr2:168112095..168114422-chr2:168116747..168119257,2	K562	blood:
6	chr2:167983370..167984614-chr2:168068319..168069263,7	MCF-7	breast:
7	chr2:168120621..168121190-chr2:168975724..168976236,2	MCF-7	breast:
8	chr2:168039379..168041883-chr2:168796886..168798758,2	K562	blood:
9	chr2:168120652..168121595-chr2:168406649..168407520,3	MCF-7	breast:
10	chr2:167756662..167757417-chr2:168068497..168069226,3	MCF-7	breast:
11	chr2:168120817..168121511-chr2:168974628..168975875,3	MCF-7	breast:
12	chr2:167756038..167756919-chr2:168067506..168068023,2	MCF-7	breast:
13	chr2:168075921..168078881-chr2:168792672..168795086,2	K562	blood:
14	chr2:168112095..168114422-chr2:168116747..168119257,2	K562	blood:
15	chr2:168082475..168084083-chr2:168084397..168086061,2	MCF-7	breast:
16	chr2:168114351..168116891-chr2:168133743..168135416,2	K562	blood:
17	chr2:167395562..167396116-chr2:168120687..168121387,2	MCF-7	breast:

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	XIRP2	hsa-miR-335-5p	chr2:168116170-168116194

Variant related genes	Relation type
XIRP2	TF binding region
XIRP2	CpG island
ENSG00000235335	chromatin interactions

Extended variants
information (count: 3768 )
Associated
traits (count: 49 )

Variant overlapped rSNPs/rCNVs (count:3768 , 50 per page) page: 1 2 3 4 5 6 7 ... 76

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10497319	chr2:168037489-168037490	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs557520865	chr2:168037504-168037505	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs554075370	chr2:168037506-168037507	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs553402792	chr2:168037527-168037528	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs533793460	chr2:168037548-168037549	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs554059854	chr2:168037549-168037550	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs1429931	chr2:168037565-168037566	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs1429932	chr2:168037614-168037615	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs561966486	chr2:168037698-168037699	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs78173096	chr2:168037709-168037710	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs368885567	chr2:168037733-168037734	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs574433019	chr2:168037750-168037751	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs61203948	chr2:168037751-168037752	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs533568811	chr2:168037783-168037784	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs547285786	chr2:168037875-168037876	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs182529381	chr2:168037881-168037882	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs6432981	chr2:168037882-168037883	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs548961245	chr2:168037884-168037885	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs112648106	chr2:168037899-168037900	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs113362505	chr2:168037905-168037906	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs200265480	chr2:168037959-168037960	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs537507179	chr2:168037991-168037992	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs6706115	chr2:168037993-168037994	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs6719812	chr2:168038037-168038038	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs533757183	chr2:168038044-168038045	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs376648086	chr2:168038050-168038051	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs11298430	chr2:168038102-168038103	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs199550174	chr2:168038113-168038114	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs553720169	chr2:168038135-168038136	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs6748606	chr2:168038152-168038153	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs536198660	chr2:168038164-168038165	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs377346281	chr2:168038186-168038187	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs185132287	chr2:168038217-168038218	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs575716402	chr2:168038232-168038233	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs190433430	chr2:168038272-168038273	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs145909550	chr2:168038273-168038274	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs6748870	chr2:168038283-168038284	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs143646082	chr2:168038284-168038285	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs540804538	chr2:168038300-168038301	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs560550984	chr2:168038362-168038363	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs529584265	chr2:168038381-168038382	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs531237302	chr2:168038398-168038399	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs562458574	chr2:168038459-168038460	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs386652430	chr2:168038473-168038474	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs185517166	chr2:168038484-168038485	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs11510359	chr2:168038506-168038507	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs189587373	chr2:168038510-168038511	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs547564492	chr2:168038526-168038527	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs180756355	chr2:168038554-168038555	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs536503827	chr2:168038572-168038573	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:49)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Mental retardation	22214275	CNVD
Glioblastoma	21080181	CNVD
small cell lung cancer	20016488	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	18414403	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	16573809	CNVD
Myelofibrosis	22110671	CNVD
Neonatal seizures	20384724	CNVD
severe myoclonic epilepsy of infancy	18294202	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Schizophrenia	21346763	CNVD

Chromatin state (count:614 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:168032600-168037600	Weak transcription	Gastric	stomach
2	chr2:168034400-168038600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
3	chr2:168036400-168039000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr2:168037200-168038000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
5	chr2:168037200-168038800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
6	chr2:168037200-168039000	Enhancers	NHEK	skin
7	chr2:168037200-168039200	Enhancers	HMEC	breast
8	chr2:168037200-168039200	Enhancers	NHLF	lung
9	chr2:168037400-168037800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
10	chr2:168037400-168038400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
11	chr2:168037400-168038400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr2:168037400-168038400	Enhancers	NHDF-Ad	bronchial
13	chr2:168037400-168038600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr2:168037400-168038800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr2:168037400-168038800	Enhancers	HSMM	muscle
16	chr2:168037400-168038800	Enhancers	NH-A	brain
17	chr2:168037400-168038800	Enhancers	Osteobl	bone
18	chr2:168037600-168037800	Enhancers	Gastric	stomach
19	chr2:168037600-168037800	Enhancers	Left Ventricle	heart
20	chr2:168037600-168039200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
21	chr2:168037800-168039000	Enhancers	Muscle Satellite Cultured Cells	--
22	chr2:168037800-168043800	Weak transcription	Gastric	stomach
23	chr2:168038000-168038400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
24	chr2:168038400-168039000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr2:168038600-168038800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr2:168038600-168042600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr2:168038800-168046200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr2:168039000-168040200	Weak transcription	Muscle Satellite Cultured Cells	--
29	chr2:168039000-168043800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr2:168039000-168048000	Weak transcription	NHEK	skin
31	chr2:168039000-168053000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr2:168039200-168046200	Weak transcription	HMEC	breast
33	chr2:168039200-168048000	Weak transcription	NHLF	lung
34	chr2:168039600-168040400	Enhancers	Fetal Brain Female	brain
35	chr2:168040200-168041600	Enhancers	Fetal Brain Male	brain
36	chr2:168040400-168043000	Weak transcription	Fetal Brain Female	brain
37	chr2:168040600-168041000	Enhancers	iPS-15b Cell Line	embryonic stem cell
38	chr2:168040600-168041000	Enhancers	Cortex derived primary cultured neurospheres	brain
39	chr2:168040800-168041000	Weak transcription	Left Ventricle	heart
40	chr2:168041000-168041200	Enhancers	Left Ventricle	heart
41	chr2:168041000-168042800	Weak transcription	Cortex derived primary cultured neurospheres	brain
42	chr2:168041200-168043000	Weak transcription	Left Ventricle	heart
43	chr2:168041600-168043000	Weak transcription	Fetal Brain Male	brain
44	chr2:168042400-168048000	Enhancers	Breast Myoepithelial Primary Cells	Breast
45	chr2:168042600-168043200	Enhancers	Skeletal Muscle Male	skeletal muscle
46	chr2:168042600-168043400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr2:168042600-168044000	Enhancers	Rectal Smooth Muscle	rectum
48	chr2:168042600-168044800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr2:168042800-168043600	Enhancers	Skeletal Muscle Female	skeletal muscle
50	chr2:168042800-168045600	Enhancers	Cortex derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links